Navigation Links
Compendia Bioscience and H3 Biomedicine Announce Strategic Collaboration to Apply Cancer Genomics to Discover and Develop Next Generation Cancer Therapeutics
Date:2/14/2012

ANN ARBOR, Mich. and CAMBRIDGE, Mass., Feb. 14, 2012 /PRNewswire-USNewswire/ -- Compendia Bioscience today announced that it has signed a three-year licensing agreement with H3 Biomedicine, Inc. to Compendia's full suite of Oncomine tools including Oncomine Concepts Edition and Oncomine Power Tools Edition.

In addition, Compendia and H3 will work together to mine data from The Cancer Genome Atlas (TCGA) to discover novel therapeutic targets and biomarkers to support drug development.

 "We are really excited to welcome H3 Biomedicine as a new partner and customer," said Daniel Rhodes, Ph.D., Compendia's co-founder and CEO. "H3 has developed a unique and compelling business strategy that is perfectly aligned with Compendia's vision for cancer drug discovery and development. We could not be more pleased to be working with them to make their vision into a reality."

"Compendia is the clear and recognized industry leader in applying cancer genomics to the discovery and development of cancer therapeutics," said Dr. Markus Warmuth, the CEO of H3 Biomedicine. "As we aim to develop H3 into a potent cancer drug discovery enterprise, it is clear that we need to partner with companies such as Compendia that think about cancer in the same way we do, that believe the development of cancer therapeutics begins with a clear understanding of the molecular characteristics and diversity of cancer patients."

About Compendia Bioscience, Inc.

Compendia Bioscience is dedicated to curing cancers through the application of genomic data by providing researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes. Visit www.compendiabio.com for more information.

About Oncomine™

Oncomine'/>"/>

SOURCE Compendia Bioscience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AAIPharma Services Announces 24/7 Online Compendial Raw Materials Testing
2. AAIPharma Services Announces Compendial Testing Facility Expansion
3. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
4. PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
5. INVO Bioscience Announces Approval of INVOcell by Brazils ANVISA
6. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
7. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
8. Roka Bioscience Awarded AOAC-RI Certification for Roka Listeria Detection Assay
9. Ambit Biosciences to Present at 30th Annual J.P. Morgan Healthcare Conference
10. Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
11. Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... FORT MYERS, Fla. , Jan. 23, 2015  Today ... approval of Novartis, Bexsero® for the prevention of ... to 25. Bexsero and Pfizer,s vaccine Trumenba®, which received ... in helping prevent this devastating disease. ...
(Date:1/23/2015)... to Fight Chronic Disease (PFCD) released a public opinion poll of ... study analyzing the impact of increased cost sharing on patient adherence ... educate policy makers and the public on the costs of chronic ... the Iowa healthcare exchange could be improved ...
(Date:1/23/2015)... than a third of reproductive-aged women enrolled in Medicaid, and ... a prescription for an opioid pain medication each year during ... Mortality Weekly Report (MMWR). Opioids are typically ... pain.  They are also found in some prescription cough medications. ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... NEW YORK, Oct. 25, 2011 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p090623/Global-Eyeglasses-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Ophthalmic_Devices This report ... Million Units and US$ Million by the ...
... SAN DIEGO, Oct. 25, 2011 Aethlon ... developing therapeutic filtration devices to address infectious disease ... A. Joyce will present a company overview, discuss ... medical device partnering conference: Investment-In-Innovation (IN3) SUMMIT on ...
Cached Medicine Technology:Global Eyeglasses Industry 2Global Eyeglasses Industry 3Global Eyeglasses Industry 4Global Eyeglasses Industry 5Global Eyeglasses Industry 6Global Eyeglasses Industry 7Global Eyeglasses Industry 8Global Eyeglasses Industry 9Global Eyeglasses Industry 10Global Eyeglasses Industry 11Global Eyeglasses Industry 12Global Eyeglasses Industry 13Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th 2
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... has released a new blog post presenting the basic features ... Purchasing an accidental death and dismemberment rider for a car ... provides benefits if the insured dies in an accident. Accidental ... life insurance. , AD&D is not expensive and can ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... Doctors at the Universities of Nottingham and Leicester are ... to image and quantify the air spaces inside the ... lead to a link between childhood disease and later ... around the world which have access to this particular ...
... and autologous stem cell transplantation, the controversial, arduous, yet ... a therapy for breast cancer, has proven not to ... node-positive disease, according to an expansive analysis conducted by ... Cancer Center. , In a review of 15 randomized ...
... sperm cells which may prevent them from being attacked by ... how some cancers spread in the human body, according to ... new research, currently available online in the Journal of Biological ... female immune system that the sperm are not dangerous pathogens, ...
... of the most debilitating of the major psychiatric disorders, and ... Although numerous antipsychotic treatments are available, they can cause significant ... of their symptoms and up to 30% no relief at ... the December 15th issue of Biological Psychiatry, Marder and colleagues ...
... Secret video key ingredient to achieving financial ... ... today by The,Money Chi that it was launching "The Power of Deliberate ... your,life through inspired action in a 7 step process. According to,inspirational author ...
... Dec. 13 Naviscan PET Systems(R), a,privately held company ... San Antonio Breast Cancer Symposium -- new clinical,data from ... cancer management., PEM Flex(TM) Solo II is a ... image small body parts such as the,breast and hand. ...
Cached Medicine News:Health News:New technique reveals insights into lung disease 2Health News:High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer 2Health News:High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer 3Health News:High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer 4Health News:Sperm's immune-protection properties could provide link to how cancers spread 2Health News:Effective new treatment for schizophrenia 2Health News:John Alexandrov Reveals 'the Secret' to Financial Success Via Launch of 'The Power of Deliberate Creation' Audio CDs 2Health News:John Alexandrov Reveals 'the Secret' to Financial Success Via Launch of 'The Power of Deliberate Creation' Audio CDs 3Health News:Naviscan's PEM Flex(TM) Scanner Shows Promising New Data in Breast Cancer Management 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: